Drug Trial Radar · NCT05635227
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Nov 10, 2022
Primary completion
Dec 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 2, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open heart surgery, including coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR) is associated with a significant risk of mortality. This study is a randomized clinical trial with the purpose of investigating four different interventions on the primary endpoint 'days alive and outside of hospital within 90 days'. The interventions are: * Dexamethasone vs. placebo administered after induction of anesthesia. * Olanzapine vs. placebo administered prior to anesthesia. * A blood-flow targeted vs. a blod-pressure targeted hemodynamic strategy while the patient is on cardio-pulmonary bypass (CPB) * Low-tidal volume ventilation vs. no ventilation of the lungs while the patient is on CPB
Conditions
- Coronary Artery Disease
- Aortic Valve Disease
Interventions
Dexamethasone phosphateDrug
See description of arms
Isotonic sodium chloride (0.9%)Drug
See description of arms
Olanzapine 10 MGDrug
Olanzapine tablet pre-hidden in capsule identical to the placebo tablet
Placebo capsuleDrug
capsule identical to capsule containing olanzapine
Flow-targeted hemodynamic managementProcedure
See description of arms
Pressure-targeted hemodynamic managementProcedure
See description of arms
Low tidal-volume ventilationProcedure
See description of arms
No ventilationProcedure
See description of arms
Primary outcomes
What the sponsor says the trial is designed to measure.
- Days alive and outside hospitalTime frame: 90 days from surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Heart Centre, Rigshospitalet
Copenhagen, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.